Lung cancer is one of the most common cancers worldwide and a leading cause of cancer-
related deaths. Macrophages play a key role in the immune response and the tumour …

Chimeric antigen receptor macrophage (CAR-MΦ) represents a significant advancement in
immunotherapy, especially for treating solid tumors where traditional CAR-T therapies face …

Recurrent breast cancers often develop resistance to standard-of-care therapies. Identifying
targetable factors contributing to cancer recurrence remains the rate-limiting step in …

Mitochondrial regulation plays a crucial role in cancer immunity in the tumor
microenvironment (TME). Infiltrating immune cells, including T cells, natural killer (NK) cells …

The tumor microenvironment (TME) is a critical determinant in the initiation, progression, and
treatment outcomes of various cancers. Comprising of cancer‐associated fibroblasts (CAF) …

The therapeutic effectiveness of photothermal therapy (PTT) is limited by heat tolerance and
PTT-induced inflammation, which increases the risk of tumor metastasis and recurrence …

Cancer is well recognized as a leading cause of mortality. Although surgery tends to be the
primary treatment option for many solid cancers, cancer surgery is still a risk factor for …

The use of antitumor drugs represents a reliable strategy for cancer therapy. Unfortunately,
drug resistance has become increasingly common and contributes to tumor metastasis and …

Simple Summary Resistance to standard therapies represents a major challenge in
melanoma treatment. This is mainly related to the high heterogeneity of this malignancy due …

The concept of nanomedicine has evolved significantly in recent decades, leveraging the
unique phenomenon known as the enhanced permeability and retention (EPR) effect. This …